These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8890899

  • 21. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): specificity and clinical associations.
    Lesavre P, Noël LH, Gayno S, Nusbaum P, Reumaux D, Erlinger S, Grünfeld JP, Halbwachs-Mecarelli L.
    J Autoimmun; 1993 Apr; 6(2):185-95. PubMed ID: 8388691
    [Abstract] [Full Text] [Related]

  • 22. The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies.
    Schultz H, Weiss J, Carroll SF, Gross WL.
    J Leukoc Biol; 2001 Apr; 69(4):505-12. PubMed ID: 11310835
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L, Radford D, Plant T, Drayson M, Adu D, Savage CO.
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [Abstract] [Full Text] [Related]

  • 25. Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).
    Vanderlocht J, van Beers JJBC, Limburg PC, Damoiseaux J, Roozendaal C.
    Methods Mol Biol; 2019 Apr; 1901():153-176. PubMed ID: 30539575
    [Abstract] [Full Text] [Related]

  • 26. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA.
    Schönermarck U, Lamprecht P, Csernok E, Gross WL.
    Rheumatology (Oxford); 2001 Feb; 40(2):178-84. PubMed ID: 11257154
    [Abstract] [Full Text] [Related]

  • 27. Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass.
    Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage CO.
    Clin Exp Immunol; 2004 Oct; 138(1):183-92. PubMed ID: 15373923
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
    Specks U, Wiegert EM, Homburger HA.
    Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
    [Abstract] [Full Text] [Related]

  • 34. Anti-neutrophil cytoplasmic antibodies directed against the bactericidal/permeability-increasing protein (BPI) in pediatric cystic fibrosis patients do not recognize N-terminal regions important for the anti-microbial and lipopolysaccharide-binding activity of BPI.
    Schultz H, Csernok E, Schuster A, Schmitz TS, Ernst M, Gross WL.
    Pediatr Allergy Immunol; 2000 May; 11(2):64-70. PubMed ID: 10893006
    [Abstract] [Full Text] [Related]

  • 35. A simple high yield procedure for purification of human proteinase 3, the main molecular target of cANCA.
    Stummann L, Wiik A.
    J Immunol Methods; 1997 Aug 07; 206(1-2):35-42. PubMed ID: 9328566
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis.
    Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage CO.
    Clin Exp Immunol; 1996 Nov 07; 106(2):273-9. PubMed ID: 8918573
    [Abstract] [Full Text] [Related]

  • 38. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
    Westman KW, Selga D, Bygren P, Segelmark M, Baslund B, Wiik A, Wieslander J.
    Kidney Int; 1998 May 07; 53(5):1230-6. PubMed ID: 9573537
    [Abstract] [Full Text] [Related]

  • 39. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
    van der Geld YM, Oost-Kort W, Limburg PC, Specks U, Kallenberg CG.
    J Immunol Methods; 2000 Oct 20; 244(1-2):117-31. PubMed ID: 11033024
    [Abstract] [Full Text] [Related]

  • 40. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
    Sun J, Fass DN, Hudson JA, Viss MA, Wieslander J, Homburger HA, Specks U.
    J Immunol Methods; 1998 Feb 01; 211(1-2):111-23. PubMed ID: 9617836
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.